Morgan Stanley Said to Consider $500 Million India Fund, Shifts some Assets

Why It Matters

The fund offers liquidity for current investors and taps growing demand for secondary‑market investments, potentially deepening capital flow into India’s healthcare sector.

Key Takeaways

• Morgan Stanley targeting $500M for India continuation fund
• Moves eight healthcare assets into new vehicle
• Omega Hospitals and RG Scientific among transferred investments
• Continuation fund reflects surge in secondary market activity
• Secondary market grew 48% to $240B in 2025

Pulse Analysis

Morgan Stanley’s decision to launch a $500 million continuation fund for Indian healthcare assets underscores a strategic pivot toward secondary‑market financing. By moving eight portfolio companies, such as Omega Hospitals and RG Scientific, into a dedicated vehicle, the firm can extend the investment horizon, offer liquidity to early backers, and attract new capital without the pressures of an IPO. This approach reflects a broader trend where private equity managers create continuation vehicles to preserve value and manage portfolio risk in volatile markets.

The secondary‑market environment has accelerated dramatically, with Jefferies reporting a 48 % jump to $240 billion in 2025. Investors increasingly favor these platforms for their ability to provide quicker exits and diversified exposure to mature assets. For Morgan Stanley, leveraging this momentum not only enhances its product suite but also positions the firm as a leader in alternative fund structures, catering to institutional demand for steady, income‑generating investments amid uncertain equity markets.

For India’s healthcare sector, the continuation fund could translate into sustained capital support for growth initiatives, technology upgrades, and expansion into underserved regions. As the fund attracts both domestic and foreign investors, it may catalyze further consolidation and innovation within the industry. Moreover, the visibility of a major global manager committing substantial resources signals confidence in India’s long‑term healthcare outlook, potentially encouraging additional foreign direct investment and reinforcing the country’s position as a burgeoning market for health‑tech and services.